文献速递类风湿关节炎脊柱关节炎

抑郁和焦虑可能降低类风湿关节炎与银屑病关节炎的缓解概率:NOR-DMARD 研究解读

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
PubMed 文献 · Ann Rheum Dis · 2017-07-21

基于前瞻性多中心 NOR-DMARD 队列,纳入 1326 例类风湿关节炎(RA)和 728 例银屑病关节炎(PsA)首次启用 TNF 抑制剂或甲氨蝶呤的患者。基线抑郁/焦虑(EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38)负向预测 RA 治疗 3 和 6 个月后多种复合缓解标准(p≤0.008),在 PsA 中部分预测(p 从 0.001 到 0.73)。基线抑郁/焦虑与随访时患者和评估者总体评估、压痛关节数及关节疼痛相关,但与肿胀关节数和急性期反应物无关。

要点

  • 基线抑郁/焦虑负向预测 RA 治疗 3 和 6 个月后复合评分缓解(p≤0.008)。
  • PsA 中抑郁/焦虑对缓解的预测作用仅部分成立(p 从 0.001 到 0.73)。
  • 抑郁/焦虑与患者/评估者总体评估、压痛关节数和关节疼痛相关,与肿胀关节数和急性期反应物无关。

核心结论

  • 抑郁和焦虑可能降低 RA 和 PsA 基于复合评分的关节缓解概率,个体化治疗目标决策时应予以考虑。

研究设计与样本

  • 前瞻性观察性多中心 NOR-DMARD 研究,纳入 1326 例 RA 和 728 例 PsA 首次启用 TNF 抑制剂或甲氨蝶呤的患者。
  • 采用预设 logistic 回归分析基线抑郁/焦虑对缓解的预测价值,预设多元线性回归分析其与缓解标准各组分的关系。

主要发现

  • 基线抑郁/焦虑(EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38)负向预测 RA 治疗 3 和 6 个月后 DAS28<2.6、SDAI≤3.3、CDAI≤2.8、ACR/EULAR 布尔缓解及 DAPSA≤4 缓解(p≤0.008)。
  • 在 PsA 中,基线抑郁/焦虑对上述缓解标准的预测作用仅部分成立(p 从 0.001 到 0.73)。
  • 基线抑郁/焦虑与 RA 随访时患者和评估者总体评估、压痛关节数及关节疼痛相关,但与肿胀关节数和急性期反应物无关。

关键数值与推荐

  • 抑郁/焦虑定义:EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38。
  • RA 缓解标准:DAS28<2.6、SDAI≤3.3、CDAI≤2.8、ACR/EULAR 布尔缓解。
  • PsA 缓解标准:DAPSA≤4。
  • 评估时间点:治疗 3 和 6 个月。

临床怎么用

  • 对 RA 和 PsA 患者制定治疗目标时,应评估并考虑抑郁/焦虑对实现复合评分缓解的潜在负面影响。
  • 抑郁/焦虑主要影响患者报告和压痛相关指标,解读缓解评估时需注意其与肿胀关节数和急性期反应物的分离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the predictive value of baseline depression/anxiety on the likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well as the associations between baseline depression/anxiety and the components of the remission criteria at follow-up. METHODS: We included 1326 patients with RA and 728 patients with PsA from the prospective observational NOR-DMARD study starting first-time tumour necrosis factor inhibitors or methotrexate. The predictive value of depression/anxiety on remission was explored in prespecified logistic regression models and the associations between baseline depression/anxiety and the components of the remission criteria in prespecified multiple linear regression models. RESULTS: Baseline depression/anxiety according to EuroQoL-5D-3L, Short Form-36 (SF-36) Mental Health subscale ≤56 and SF-36 Mental Component Summary ≤38 negatively predicted 28-joint Disease Activity Score <2.6, Simplified Disease Activity Index ≤3.3, Clinical Disease Activity Index ≤2.8, ACR/EULAR Boolean and Disease Activity Index for Psoriatic Arthritis ≤4 remission after 3 and 6 months treatment in RA (p≤0.008) and partly in PsA (p from 0.001 to 0.73). Baseline depression/anxiety was associated with increased patient's and evaluator's global assessment, tender joint count and joint pain in RA at follow-up, but not with swollen joint count and acute phase reactants. CONCLUSION: Depression and anxiety may reduce likelihood of joint remission based on composite scores in RA and PsA and should be taken into account in individual patients when making a shared decision on a treatment target.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017. PMID: 28733473. doi:10.1136/annrheumdis-2017-211284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。